Investor Relations
-
Message from the Chairman and CEO
We are working to meet the expectations of our shareholders and investors by enhancing corporate value.
Message from the Chairman and CEO
We are working to meet the expectations of our shareholders and investors by enhancing corporate value.
-
Stock Price
Last-
Change-
Chart
IR Topics
-
News Releases
-
Sysmex Obtains Manufacturing and Marketing Approval for Novel Coronavirus Detection Reagent (RT-PCR Method)
- Building a Self-Sufficient Production System in Japan for a Stable Supply of PCR Testing Kits - (PDF：169KB) -
News Releases
-
Sysmex Continues to Evolve Its Hematology Product Portfolio
- Flagship Model XR-Series and Compact 3-part WBC Differential Model XQ-Series to Be Rolled Out Sequentially - (PDF：209KB) -
IR Topics
- Posted Our Company Briefing Presentation for Our Stakeholders
-
News Releases
- Announcement of Organizational and Personnel Changes (PDF：385KB)
-
News Releases
-
Sysmex Presents Academic Report on Creating a Simple Method of Diagnosing Alzheimer’s Disease Using Blood
- Presenting the Most Recent Data at the 15th International Conference on Alzheimer’s & Parkinson’s Diseases (AD/PD 2021) - (PDF：118KB)
Download the Latest IR Materials
Click Here
for File Details
Data Included in the Zip File
Consolidated Financial Results for First Nine Months of Fiscal Year Ending March 31, 2021- Financial Statements
- Presentation
- Financial Data
